tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SNY Stock Latest News

Sanofi initiated with an Outperform at BNP Paribas Exane
The FlySanofi initiated with an Outperform at BNP Paribas Exane
57m ago
SNY
Sanofi’s Strong Financial Performance and Promising Growth Prospects Earn a Buy Rating
PremiumRatings
Sanofi’s Strong Financial Performance and Promising Growth Prospects Earn a Buy Rating
1d ago
SNY
Novavax price target lowered to $10 from $12 at BofA
PremiumThe Fly
Novavax price target lowered to $10 from $12 at BofA
5d ago
SNY
NVAX
Sanofi’s Tolebrutinib Shows Promise in Phase 3 Study for Multiple Sclerosis
PremiumCompany Announcements
Sanofi’s Tolebrutinib Shows Promise in Phase 3 Study for Multiple Sclerosis
5d ago
6K
SNY
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
PremiumThe Fly
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
6d ago
AZN
BMY
Sanofi announces publication of tolebrutinib Phase 3 data in NEJM
PremiumThe FlySanofi announces publication of tolebrutinib Phase 3 data in NEJM
7d ago
SNY
IGM Biosciences downgraded to Underperform from Neutral at BofA
Premium
The Fly
IGM Biosciences downgraded to Underperform from Neutral at BofA
7d ago
SNY
IGMS
Sanofi’s Rilzabrutinib Gains Orphan Drug Status for Rare Diseases
Premium
Company Announcements
Sanofi’s Rilzabrutinib Gains Orphan Drug Status for Rare Diseases
11d ago
6K
SNY
Nurix Therapeutics announces Sanofi exclusively licensed a program
PremiumThe Fly
Nurix Therapeutics announces Sanofi exclusively licensed a program
13d ago
SNY
NRIX
Sanofi’s Dupixent Gains Approval in Japan for COPD Treatment
PremiumCompany Announcements
Sanofi’s Dupixent Gains Approval in Japan for COPD Treatment
13d ago
6K
SNY
Sanofi’s Strong Growth Potential: Buy Rating Backed by Attractive Valuation and Robust Pipeline
PremiumRatings
Sanofi’s Strong Growth Potential: Buy Rating Backed by Attractive Valuation and Robust Pipeline
13d ago
SNY
Sanofi treatment of immunoglobulin G4-related disease granted orphan status
PremiumThe Fly
Sanofi treatment of immunoglobulin G4-related disease granted orphan status
14d ago
SNY
Cautious Hold Rating on Sanofi Due to Safety Concerns and Limited Growth Prospects for Qfitlia
PremiumRatingsCautious Hold Rating on Sanofi Due to Safety Concerns and Limited Growth Prospects for Qfitlia
15d ago
SNY
Alnylam announces FDA approval of Qfitlia for treatment of hemophilia A or B
Premium
The Fly
Alnylam announces FDA approval of Qfitlia for treatment of hemophilia A or B
18d ago
SNY
ALNY
FDA approves Sanofi treatment for hemophilia A or B
Premium
The Fly
FDA approves Sanofi treatment for hemophilia A or B
18d ago
SNY
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
18d ago
PTN
SNY
Regeneron (NASDAQ:REGN) and Sanofi Get Japan Green Light for Smokers’ Lung Disease Treatment
PremiumMarket News
Regeneron (NASDAQ:REGN) and Sanofi Get Japan Green Light for Smokers’ Lung Disease Treatment
18d ago
SNY
Regeneron, Sanofi announce Dupixent authorization in Japan
PremiumThe Fly
Regeneron, Sanofi announce Dupixent authorization in Japan
18d ago
SNY
REGN
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
PremiumThe Fly
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
19d ago
AZN
BMY
Sanofi’s Tolebrutinib and Chlamydia Vaccine Achieve Regulatory Milestones
PremiumCompany AnnouncementsSanofi’s Tolebrutinib and Chlamydia Vaccine Achieve Regulatory Milestones
20d ago
6K
SNY
U.S. to end funding for child vaccines in developing countries, NY Times reports
Premium
The Fly
U.S. to end funding for child vaccines in developing countries, NY Times reports
20d ago
AZN
GSK
Large pharma M&A deals stalling amid volatile policies, Reuters reports
Premium
The Fly
Large pharma M&A deals stalling amid volatile policies, Reuters reports
20d ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >